On April 17, 2025 MOMA Therapeutics, a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, reported three poster presentations at the 2025 American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting, being held April 25 – 30, 2025 in Chicago, IL (Press release, MOMA Therapeutics, APR 17, 2025, View Source [SID1234651984]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
AACR poster presentation details are below:
MOMA-313 is a potent and selective inhibitor of the Polθ DNA helicase domain for the treatment of HR-deficient tumors
Session Title: PO.ET09.05 – Novel Antitumor Agents 1
Location: Section 22
Abstract Number: 1749
Date/Time: April 28, 2025, 9:00 a.m. – 12:00 p.m. CT
Presenting Author: Jordan Krall, Ph.D.
TA repeat expansion outperforms MSI-H status as a predictor of sensitivity to the novel WRN inhibitor MOMA-341
Session Title: PO.ET06.07 – DNA Damage Response and Modulation of DNA Repair 2
Location: Section 15
Abstract Number: 4205
Date/Time: April 29, 2025, 9:00 a.m. – 12:00 p.m. CT
Presenting Author: Allison Drew
Orally Administered MOMA-313 as Monotherapy or Combination Therapy in Participants with Advanced or Metastatic Solid Homologous Recombination (HR)-Deficient Tumors: Phase 1 Study Design
Session Title: CTP01.02 – Phase I Clinical Trials in Progress 2
Location: Section 50
Abstract Number: CT192
Date/Time: April 29, 2025, 9:00 a.m. – 12:00 p.m. CT
Presenting Author: Amita Patnaik, M.D.
Abstracts are currently available on the AACR (Free AACR Whitepaper) website. The posters can be accessed through the "News & Publications" tab on the MOMA Therapeutics website at the time of each presentation’s starting session.